Two-year durability of REBYOTA™ (RBL), a live biotherapeutic for the prevention of recurrent Clostridioides difficile infections

Detalles Bibliográficos
Autores principales: Orenstein, Robert, Hecht, Gail, Harvey, Adam, Tillotson, Glenn, Khanna, Sahil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Insight Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485881/
https://www.ncbi.nlm.nih.gov/pubmed/37691735
http://dx.doi.org/10.1093/ofid/ofad456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485881/
https://www.ncbi.nlm.nih.gov/pubmed/37691735
http://dx.doi.org/10.1093/ofid/ofad456

Ejemplares similares